These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38713975)

  • 1. Advanced therapeutic approaches in sarcoglycanopathies.
    Scano M; Benetollo A; Dalla Barba F; Sandonà D
    Curr Opin Pharmacol; 2024 Jun; 76():102459. PubMed ID: 38713975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
    Carotti M; Marsolier J; Soardi M; Bianchini E; Gomiero C; Fecchio C; Henriques SF; Betto R; Sacchetto R; Richard I; Sandonà D
    Hum Mol Genet; 2018 Mar; 27(6):969-984. PubMed ID: 29351619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoglycanopathies: an update.
    Vainzof M; Souza LS; Gurgel-Giannetti J; Zatz M
    Neuromuscul Disord; 2021 Oct; 31(10):1021-1027. PubMed ID: 34404573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.
    Pozsgai ER; Griffin DA; Heller KN; Mendell JR; Rodino-Klapac LR
    Gene Ther; 2016 Jan; 23(1):57-66. PubMed ID: 26214262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart involvement in sarcoglycanopathies].
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Rev Neurol (Paris); 2012 Nov; 168(11):779-82. PubMed ID: 22405990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery.
    Carotti M; Scano M; Fancello I; Richard I; Risato G; Bensalah M; Soardi M; Sandonà D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcoglycanopathies: state of the art and therapeutic perspectives].
    Fernández-Eulate G; Leturcq F; Laforêt P; Richard I; Stojkovic T
    Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():22-27. PubMed ID: 33427632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoglycanopathies.
    Kirschner J; Lochmüller H
    Handb Clin Neurol; 2011; 101():41-6. PubMed ID: 21496623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.
    Wyatt EJ; Demonbreun AR; Kim EY; Puckelwartz MJ; Vo AH; Dellefave-Castillo LM; Gao QQ; Vainzof M; Pavanello RCM; Zatz M; McNally EM
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D.
    Mojbafan M; Nilipour Y; Tonekaboni SH; Tavakkoly-Bazzaz J; Zeinali S
    Neurol Res; 2016 Mar; 38(3):220-3. PubMed ID: 27093116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Systemic Delivery of Adeno-Associated α-Sarcoglycan Gene Transfer for Limb-Girdle Muscular Dystrophy.
    Griffin DA; Pozsgai ER; Heller KN; Potter RA; Peterson EL; Rodino-Klapac LR
    Hum Gene Ther; 2021 Apr; 32(7-8):390-404. PubMed ID: 33349138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.
    Alonso-Pérez J; González-Quereda L; Bruno C; Panicucci C; Alavi A; Nafissi S; Nilipour Y; Zanoteli E; Isihi LMA; Melegh B; Hadzsiev K; Muelas N; Vílchez JJ; Dourado ME; Kadem N; Kutluk G; Umair M; Younus M; Pegorano E; Bello L; Crawford TO; Suárez-Calvet X; Töpf A; Guglieri M; Marini-Bettolo C; Gallano P; Straub V; Díaz-Manera J
    Brain; 2022 Apr; 145(2):596-606. PubMed ID: 34515763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different outcome of sarcoglycan missense mutation between human and mouse.
    Henriques SF; Patissier C; Bourg N; Fecchio C; Sandona D; Marsolier J; Richard I
    PLoS One; 2018; 13(1):e0191274. PubMed ID: 29360879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late-onset limb-girdle muscular dystrophy type 2D: A milder form with a normal muscle biopsy.
    Oliveira Santos M; Coelho P; Roque R; Conceição I
    J Clin Neurosci; 2020 Feb; 72():471-473. PubMed ID: 31836381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
    Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
    Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
    Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
    Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D.
    Bianchini E; Fanin M; Mamchaoui K; Betto R; Sandonà D
    Hum Mol Genet; 2014 Jul; 23(14):3746-58. PubMed ID: 24565866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milder forms of α-sarcoglicanopathies diagnosed in adulthood by NGS analysis.
    Cantero D; Hernández-Laín A; Martínez JFG; Pérez MR; Ruano Y; Lleixà C; Gallardo E; Domínguez-González C
    J Neurol Sci; 2018 Nov; 394():63-67. PubMed ID: 30218921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
    Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
    Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic AAV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice.
    Pozsgai ER; Griffin DA; Heller KN; Mendell JR; Rodino-Klapac LR
    Mol Ther; 2017 Apr; 25(4):855-869. PubMed ID: 28284983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.